Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
Not Confirmed
Not Confirmed
17-21 August, 2025
The Bioprocessing Summ...The Bioprocessing Summit
Not Confirmed
Not Confirmed
18-21 August, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
Industry Trade Show
Not Confirmed
17-21 August, 2025
The Bioprocessing Summ...The Bioprocessing Summit
Industry Trade Show
Not Confirmed
18-21 August, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
31 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250731014937/en/BeOne-Medicines-Receives-PRIME-Designation-from-the-European-Medicines-Agency-for-BGB-16673-in-Waldenstroms-Macroglobulinemia
28 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250728331235/en/BeOne-Medicines-Receives-Positive-CHMP-Opinion-for-TEVIMBRA-in-NeoadjuvantAdjuvant-NSCLC-Treatment
16 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250716492641/en/BeOne-Medicines-to-Announce-Second-Quarter-2025-Financial-Results-on-August-6
10 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250710356913/en/European-Commission-Approves-TEVIMBRA-in-Combination-with-Chemotherapy-as-a-First-Line-Treatment-for-Nasopharyngeal-Carcinoma
09 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250709188805/en/Biocytogen-Enters-into-Antibody-Licensing-Agreement-with-BeOne-Medicines-to-Accelerate-Innovative-Drug-Development
26 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250626270573/en/BeOne-Medicines-Showcases-Groundbreaking-Oncology-Pipeline-at-RD-Day
ABOUT THIS PAGE